The UMD-FBN1 mutations database
Record ID: 278

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.6158G>Tp.Cys2053PheHeterozygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
TGCCysTTCPheG->TTv

StructureKey Residue (HCD)Pyrimidin doubletCpG
cb EGF-like #31 Disulfide bonds 2040-2053 (C6)NoNo

Mutation impact


At the mRNA levelOn restriction map
NANew restriction site(s): none
Lost restriction site(s): none

Conservation (0-1)SIFT (0-1)UMD-predictor (0-100)
10.00 (pathogenous)100 (Pathogenous)

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
USA03STA F0061 I25ProbandNANA? (28 years old)U.S.A

Phenotypic groupDisease
Type IClassical MFS

Clinical data


SymptomSeverity
C-Mitral valve prolapse
L-Spontaneous pneumothorax
O-Ectopia lentisbilateral
O-Myopia
S-Arachnodactyly (M)
S-Crowding teeth (m)
S-Dolichostenomelia
S-Joint limitations
S-Scoliosis > 20° (M)(1)mild
SI-Significant striae atrophicae (m)(1)

Reference


Reference IDPubMed IDReference
5710486319
Schrijver I, Liu W, Brenn T, Furthmayr H, Francke U. "Cysteine Substitutions in Epidermal Growth Factor-Like Domains of Fibrillin-1: Distinct Effects on Biochemical and Clinical Phenotypes". Am J Hum Genet 1999 Oct;65(4):1007-1020.